Tailored projects delivering reliable data and exceptional service

We aim to meet your unique requirements for experimental design and analysis output, while exceeding service expectations with our "white-gloved" approach.

  • Consult with your dedicated project team to define project scope timelines
  • Receive frequent and regular status updates
  • Obtain comprehensive, in-depth analysis of results

Book consultation

Custom drug screening poster

Poster: Custom drug screening

See how combination drug screens helped discover agents resulting in enhanced efficacy in pre-clinical models of multiple myeloma.

'ATL313, A Potent, and Selective A2A Agonist as a Novel Drug Candidate for the Treatment of Multiple Myeloma'

Screen in physiologically relevant 3D models

Perform drug screens 200 cell lines from our OncoSignature™ library grown in 3D spheroids.

Combine with apoptosis assays

Rapidly screen agents on their capacity of inducing cell apoptosis in a broad panel of cell types.

Custom screening options

  • Select from over 650 cancer cell lines or 4000+ isogenic mutant and wild type cell pairs
  • Bench-marking against a choice of over 350 standard-of-care drugs
  • Flexible options: dose matrix format, assay endpoints, drug sequencing and environmental conditions, 2D versus 3D models
  • Identify molecular features responsive to your therapeutic
  • Interpretative report or combination analysis

Also available

Enhancer Screening

Look for selective pipeline candidate enhancers, approved therapeutics, emerging targeted agents and molecular probes.


Enhancer Screening Diagram 1


Pairwise Screening

Identify novel synergistic combinations of pipeline candidates, emerging targeted agents, and approved drugs.